NovaBridge Biosciences (NBP) Other Accumulated Expenses (2022 - 2025)

NovaBridge Biosciences (NBP) has 4 years of Other Accumulated Expenses data on file, last reported at $9.2 million in Q4 2025.

• Other Accumulated Expenses for Q4 2025 came in at $9.2 million, up 8560.38% year-over-year; the trailing twelve-month figure through Dec 2025 was $9.2 million (up 8560.38% YoY), and the FY2025 annual result was $9.2 million, up 8560.38% from the prior year.
• Other Accumulated Expenses improved to $9.2 million in Q4 2025 per NBP's latest filing, from $106000.0 in the prior quarter.
• Over five years, Other Accumulated Expenses peaked at $9.2 million in Q4 2025 and troughed at $106000.0 in Q4 2024.
• A 4-year average of $5.8 million and a median of $7.0 million in 2022 frame the typical range for Other Accumulated Expenses.
• The sharpest annual moves came in 2024 and 2025: Other Accumulated Expenses tumbled 97.82% in 2024, then jumped 8560.38% in 2025.
• A 4-year view of Other Accumulated Expenses shows it stood at $9.1 million in 2022, then tumbled by 46.54% to $4.9 million in 2023, then plunged by 97.82% to $106000.0 in 2024, then jumped by 8560.38% to $9.2 million in 2025.
• Business Quant data shows NBP's Other Accumulated Expenses at $9.2 million in Q4 2025, $106000.0 in Q4 2024, and $4.9 million in Q4 2023.